InsiderClue
← All stocks

Corbus Pharmaceuticals Holdings, Inc.

CRBP Net buying
CIK 0001595097 #3966 in the set updated 17 Sep 2026
Bought (120 mo)
$54.96M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.94M
$643.17K on a plan · $4.81M straight out of an exercise
Sold at will
$490.31K
6 of 37 sales
Net
+$49.02M
+$54.47M against sales at will

By person

22 insiders · 140 transactions
1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
10% owner
$53.69M (31)
$344.01K (1)
+$53.35M
2,344,971
12.12%
$18.39M
+430.1%
Cohen Yuval
Chief Executive Officer
$122.23K (15)
$3.76M (13) scheduled
−$3.64M
157,316
0.8134%
$1.23M
—
Moran Sean F.
Chief Financial Officer
$144.20K (12)
$1.54M (11) scheduled
−$1.40M
84,694
0.4379%
$664.13K
—
Hochman David P
Director
$269.18K (7)
—
+$269.18K
814,400
4.21%
$6.39M
+5.9%
White Barbara
Chief Medical Officer
$254.36K (12)
—
+$254.36K
206,217
1.07%
$1.62M
+28.0%
Saxena Nishant C
Chief Business Officer
$126.25K (3)
—
+$126.25K
77,900
0.4028%
$610.85K
+2,126%
Smethurst Dominic
Chief Medical Officer
—
$120.51K (3)
−$120.51K
89,790
0.4642%
$704.09K
—
Discordia Robert Paul
Chief Operating Officer
$109.51K (3)
—
+$109.51K
35,490
0.1835%
$278.29K
+134.3%
Panayiotopoulos Paris
Director
$100.39K (1)
—
+$100.39K
14,285
0.0739%
$112.02K
—
Millian Craig Stuart
Chief Operating Officer
$76.55K (8)
—
+$76.55K
27,000
0.1396%
$211.72K
—
Jenkins John Kenneth
Director
$6.98K (1)
$58.45K (2) scheduled
−$51.47K
3,833
0.0198%
$30.06K
—
Altmeyer Anne
Director
—
$50.91K (3) scheduled
−$50.91K
7,579
0.0392%
$59.43K
—
CATLIN AVERY W
Director
$45.84K (2)
—
+$45.84K
4,350
0.0225%
$34.11K
—
Hodgson Ian
Chief Operating Officer
—
$25.79K (2)
−$25.79K
51,080
0.2641%
$400.54K
+96.6%
Kung Winston
Director
—
$16.03K (1) scheduled
−$16.03K
12,140
0.0628%
$95.20K
—
Ben Yong
Director
—
$15.68K (1) scheduled
−$15.68K
9,383
0.0485%
$73.58K
—
HOLMER ALAN F
Director
$10.61K (2)
—
+$10.61K
10,629
0.0550%
$83.35K
—
Tepper Mark
President and CSO
—
—
—
2,110,400
10.91%
$16.55M
+0.5%
Nicacio Leonardo Viana
Chief Medical Officer
—
—
—
58,333
0.3016%
$457.42K
—
Jacques Rachelle Suzanne
Director
—
—
—
11,383
0.0589%
$89.26K
—
Pfeiffenberger Brent
Director
—
—
—
7,500
0.0388%
$58.81K
—
Salzmann Peter
Director
—
—
—
2,783
0.0144%
$21.82K
—

Individual transactions

97
Insider
Date
Role
Action
Shares
Price
Amount
Saxena Nishant C
11 Aug 2026
Chief Business Officer
Buy
2,600
$9.63
$25.04K
Saxena Nishant C
3 Jun 2026
Chief Business Officer
Buy
9,000
$7.58
$68.22K
Saxena Nishant C
2 Jun 2026
Chief Business Officer
Buy
4,500
$7.33
$33.00K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
25,769
$22.23
$572.79K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
47,564
$21.47
$1.02M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
139,551
$20.42
$2.85M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
66,088
$19.61
$1.30M
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
25,943
$18.36
$476.31K
Cormorant Asset Management, LP
20 Sep 2024
10% owner
Buy indirect
45,085
$17.48
$787.86K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
8,862
$45.96
$407.30K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
156,597
$45.26
$7.09M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
61,668
$44.62
$2.75M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
18,548
$43.26
$802.39K
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
24,983
$42.25
$1.06M
Cormorant Asset Management, LP
8 Mar 2024
10% owner
Buy indirect
29,342
$41.23
$1.21M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
102,140
$41.23
$4.21M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
90,325
$39.99
$3.61M
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
10,736
$39.13
$420.10K
Cormorant Asset Management, LP
7 Mar 2024
10% owner
Buy indirect
46,799
$37.82
$1.77M
Cormorant Asset Management, LP
2 Feb 2024
10% owner
Buy indirect
750,000
$19.00
$14.25M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
3,200
$38.49
$123.17K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
43,754
$37.49
$1.64M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
16,484
$36.53
$602.16K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
32,295
$35.83
$1.16M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
31,549
$34.62
$1.09M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
18,055
$33.71
$608.63K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
3,866
$32.47
$125.53K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
4,125
$31.86
$131.42K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
2,654
$31.00
$82.27K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
29,244
$29.42
$860.36K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
31,028
$28.82
$894.23K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
36,747
$27.70
$1.02M
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
15,243
$26.66
$406.38K
Cormorant Asset Management, LP
26 Jan 2024
10% owner
Buy indirect
14,388
$25.73
$370.20K
Moran Sean F.
10 Aug 2022
Chief Financial Officer
Buy
20,000
$0.26
$5.20K
Cohen Yuval
10 Aug 2022
Chief Executive Officer
Buy
3,800
$0.26
$1.00K
Millian Craig Stuart
10 Aug 2022
Chief Operating Officer
Buy
5,000
$0.25
$1.27K
Cohen Yuval
16 May 2022
Chief Executive Officer
Buy
10,500
$0.25
$2.63K
Moran Sean F.
16 May 2022
Chief Financial Officer
Buy
12,000
$0.30
$3.60K
Moran Sean F.
10 Mar 2022
Chief Financial Officer
Buy
15,000
$0.37
$5.55K
Millian Craig Stuart
10 Mar 2022
Chief Operating Officer
Buy
10,000
$0.37
$3.70K
Cohen Yuval
9 Mar 2022
Chief Executive Officer
Buy
8,600
$0.37
$3.18K
Cohen Yuval
11 Nov 2020
Chief Executive Officer
Buy
4,240
$1.21
$5.13K
Cohen Yuval
17 Mar 2020
Chief Executive Officer
Buy
4,300
$3.49
$15.01K
White Barbara
17 Mar 2020
Chief Medical Officer
Buy
15,606
$3.63
$56.65K
Discordia Robert Paul
17 Mar 2020
Chief Operating Officer
Buy
2,840
$3.54
$10.05K
Millian Craig Stuart
17 Mar 2020
Chief Commercial Officer
Buy
2,000
$4.25
$8.50K
Cohen Yuval
12 Nov 2019
Chief Executive Officer
Buy
1,430
$4.26
$6.09K
White Barbara
12 Nov 2019
Chief Medical Officer
Buy
3,424
$4.38
$14.99K
Discordia Robert Paul
11 Nov 2019
Chief Operating Officer
Buy
2,500
$4.62
$11.56K
Millian Craig Stuart
11 Nov 2019
Chief Commercial Officer
Buy
1,000
$4.38
$4.38K
Millian Craig Stuart
15 Aug 2019
Chief Commercial Officer
Buy
1,500
$5.48
$8.21K
Discordia Robert Paul
12 Aug 2019
Chief Operating Officer
Buy
15,000
$5.86
$87.89K
Cohen Yuval
12 Aug 2019
Chief Executive Officer
Buy
1,175
$6.06
$7.12K
Millian Craig Stuart
12 Aug 2019
Chief Commercial Officer
Buy
1,500
$6.00
$9.00K
White Barbara
12 Aug 2019
Chief Medical Officer
Buy
1,639
$6.10
$10.00K
White Barbara
17 May 2019
Chief Medical Officer
Buy
1,389
$7.20
$10.00K
Moran Sean F.
14 May 2019
Chief Financial Officer
Buy
100
$7.12
$712.00
Millian Craig Stuart
14 May 2019
Chief Commercial Officer
Buy
1,000
$7.23
$7.23K
Cohen Yuval
13 May 2019
Chief Executive Officer
Buy
995
$6.99
$6.95K
Jenkins John Kenneth
15 Mar 2019
Director
Buy
1,000
$6.98
$6.98K
Hochman David P
15 Mar 2019
Director
Buy indirect
2,000
$6.98
$13.96K
Cohen Yuval
14 Mar 2019
Chief Executive Officer
Buy
1,530
$6.49
$9.93K
Moran Sean F.
14 Mar 2019
Chief Financial Officer
Buy
1,500
$6.67
$10.01K
White Barbara
14 Mar 2019
Chief Medical Officer
Buy
4,638
$6.47
$29.99K
Millian Craig Stuart
14 Mar 2019
Chief Commercial Officer
Buy
5,000
$6.85
$34.26K
Moran Sean F.
15 May 2018
Chief Financial Officer
Buy
4,000
$5.77
$23.08K
Cohen Yuval
15 May 2018
Chief Executive Officer
Buy
1,725
$5.85
$10.09K
White Barbara
15 May 2018
Chief Medical Officer
Buy
2,586
$5.87
$15.17K
Hochman David P
14 May 2018
Director
Buy indirect
5,000
$5.48
$27.38K
Moran Sean F.
14 Mar 2018
Chief Financial Officer
Buy
3,100
$6.60
$20.46K
Cohen Yuval
14 Mar 2018
Chief Executive Officer
Buy
1,160
$6.89
$7.99K
White Barbara
14 Mar 2018
Chief Medical Officer
Buy
2,885
$6.89
$19.88K
Hochman David P
14 Mar 2018
Director
Buy indirect
5,000
$6.67
$33.33K
Panayiotopoulos Paris
16 Nov 2017
Director
Buy
14,285
$7.03
$100.39K
Hochman David P
15 Nov 2017
Director
Buy indirect
5,000
$6.55
$32.75K
Cohen Yuval
10 Nov 2017
Chief Executive Officer
Buy
1,000
$7.17
$7.17K
Hochman David P
10 Nov 2017
Director
Buy
10,000
$7.08
$70.80K
White Barbara
10 Nov 2017
Chief Medical Officer
Buy
2,836
$7.00
$19.85K
Moran Sean F.
10 Nov 2017
Chief Financial Officer
Buy
1,500
$7.04
$10.56K
Moran Sean F.
11 Aug 2017
Chief Financial Officer
Buy
2,500
$5.91
$14.78K
Cohen Yuval
11 Aug 2017
Chief Executive Officer
Buy
1,695
$6.00
$10.17K
White Barbara
11 Aug 2017
Chief Medical Officer
Buy
2,479
$6.05
$15.00K
Cohen Yuval
11 May 2017
Chief Executive Officer
Buy
3,250
$6.01
$19.54K
White Barbara
11 May 2017
Chief Medical Officer
Buy
2,435
$6.12
$14.90K
CATLIN AVERY W
11 May 2017
Director
Buy
5,000
$6.15
$30.74K
Hochman David P
11 May 2017
Director
Buy
3,400
$6.18
$21.01K
HOLMER ALAN F
11 May 2017
Director
Buy
500
$6.23
$3.12K
Moran Sean F.
11 May 2017
Chief Financial Officer
Buy
3,300
$6.14
$20.26K
White Barbara
17 Mar 2017
Chief Medical Officer
Buy
4,233
$9.49
$40.17K
Moran Sean F.
13 Mar 2017
Chief Financial Officer
Buy
2,000
$9.60
$19.20K
Moran Sean F.
2 Dec 2016
Chief Financial Officer
Buy
1,500
$7.20
$10.80K
CATLIN AVERY W
22 Nov 2016
Director
Buy
2,000
$7.55
$15.10K
HOLMER ALAN F
22 Nov 2016
Director
Buy
1,000
$7.49
$7.49K
Cohen Yuval
22 Nov 2016
Chief Executive Officer
Buy
1,340
$7.64
$10.24K
White Barbara
22 Nov 2016
Chief Medical Officer
Buy
1,000
$7.75
$7.75K
Hochman David P
18 Nov 2016
Director
Buy
10,000
$7.00
$69.96K
Show all 140 transactions →

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 19
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 1,398,906
History held since 8 Sep 2016